Long-Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus
Arthritis Rheumatol . 2018 Jun;70(6):868-877
This long-term Phase 3 study confirmed the safety and efficacy of belimumab in patients with SLE.
At Year 7, over three-quarters of patients demonstrates a SRI response, while rates of AEs and SAEs remained stable or declined.
Keywords:
